相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methodological considerations when analysing and interpreting real-world data
Til Sturmer et al.
RHEUMATOLOGY (2020)
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Kelvin Chan et al.
BMJ OPEN (2020)
Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative
Michael Happich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Bridging observational studies and randomized experiments by embedding the former in the latter
Marie-Abele C. Bind et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools
Joan M. Quigley et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2019)
Threshold Analysis as an Alternative to GRADE for Assessing Confidence in Guideline Recommendations Based on Network Meta-analyses
David M. Phillippo et al.
ANNALS OF INTERNAL MEDICINE (2019)
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
Alison Cave et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The hierarchical metaregression approach and learning from clinical evidence
Pablo Emilio Verde
BIOMETRICAL JOURNAL (2019)
Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust
Elisabeth M. Oehrlein et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2019)
An overview of methods for network meta-analysis using individual participant data: when do benefits arise?
Thomas P. A. Debray et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations
Monika Mueller et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)
Hongbo Yuan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
The inclusion of real world evidence in clinical development planning
Reynaldo Martina et al.
TRIALS (2018)
Real-World Evidence in the Real World: Beyond the FDA
Joan H. Krause et al.
AMERICAN JOURNAL OF LAW & MEDICINE (2018)
Estimating and contextualizing the attenuation of odds ratios due to non collapsibility
Stephen Burgess
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS (2017)
A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement
Petra Schnell-Inderst et al.
HEALTH ECONOMICS (2017)
Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation
Ewelina Rogozinska et al.
HEALTH TECHNOLOGY ASSESSMENT (2017)
Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Shirley V. Wang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L. Berger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Combining randomized and nonrandomized evidence in network meta-analysis
Orestis Efthimiou et al.
STATISTICS IN MEDICINE (2017)
Guidelines for good pharmacoepidemiology practice (GPP)
Elizabeth B. Andrews et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: A mixed methods study
Elena Nicod et al.
HEALTH POLICY (2016)
Standards and guidelines for observational studies: quality is in the eye of the beholder
Sally C. Morton et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Propensity score estimators for the average treatment effect and the average treatment effect on the treated may yield very different estimates
R. Pirracchio et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2016)
Plea for routinely presenting prediction intervals in meta-analysis
Joanna IntHout et al.
BMJ OPEN (2016)
Combining randomized and non-randomized evidence in clinical research: a review of methods and applications
Pablo E. Verde et al.
RESEARCH SYNTHESIS METHODS (2015)
The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses
W. G. Melsen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Good practices for quantitative bias analysis
Timothy L. Lash et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
The risks of methodology aversion in drug regulation
Peter Bauer et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
Marc L. Berger et al.
VALUE IN HEALTH (2014)
Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid
Trisha F. Hue et al.
JAMA INTERNAL MEDICINE (2014)
Recovering the raw data behind a non-parametric survival curve
Zhihui Liu et al.
SYSTEMATIC REVIEWS (2014)
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials
Andrew Anglemyer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Evidence Synthesis for Decision Making 7: A Reviewer's Checklist
A. E. Ades et al.
MEDICAL DECISION MAKING (2013)
Incorporating data from various trial designs into a mixed treatment comparison model
Susanne Schmitz et al.
STATISTICS IN MEDICINE (2013)
Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions
Holger J. Schuenemann et al.
RESEARCH SYNTHESIS METHODS (2013)
Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews
George A. Wells et al.
RESEARCH SYNTHESIS METHODS (2013)
Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes
Issa J. Dahabreh et al.
EUROPEAN HEART JOURNAL (2012)
Detecting and adjusting for small-study effects in meta-analysis
Gerta Ruecker et al.
BIOMETRICAL JOURNAL (2011)
A proposed method of bias adjustment for meta-analyses of published observational studies
Simon Thompson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Commentary: Adjusting for bias: a user's guide to performing plastic surgery on meta-analyses of observational studies
John P. A. Ioannidis
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Establishing a Minimum Dataset for Prospective Registration of Systematic Reviews: An International Consultation
Alison Booth et al.
PLOS ONE (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Bias modelling in evidence synthesis
Rebecca M. Turner et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II
Emily Cox et al.
VALUE IN HEALTH (2009)
Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part III
Michael L. Johnson et al.
VALUE IN HEALTH (2009)
Systematic differences in treatment effect estimates between propensity score methods and logistic regression
Edwin P. Martens et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified
Julian P. T. Higgins
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration
Jan P. Vandenbroucke et al.
PLOS MEDICINE (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Why most published research findings are false
JPA Ioannidis
PLOS MEDICINE (2005)
Multiple-bias modelling for analysis of observational data
S Greenland
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2005)
Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence
NF Col et al.
BREAST CANCER RESEARCH (2005)
Adjusted likelihoods for synthesizing empirical evidence from studies that differ in quality and design: Effects of environmental tobacco smoke
RL Wolpert et al.
STATISTICAL SCIENCE (2004)
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors
CH Schmid et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling
DJ Spiegelhalter et al.
STATISTICS IN MEDICINE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
